Medicare Enrolled
Fatema Esmail
Hematology & Oncology · Arlington Heights, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Esmail from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Esmail?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Esmail
Fatema Esmail is a hematology & oncology specialist in Arlington Heights, IL, with 12 years of NPI registration. Based on federal Medicare data, Esmail performed 35,895 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Esmail received a total of $7,732 from 54 pharmaceutical and/or device companies across 226 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Esmail is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years of NPI registration
▲ Top 25% volume in IL
$7,732 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗35,895
Medicare services
Top 25% in IL for hematology & oncology
Not available
Unique patients (not deduplicated)
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
18,150 | $0 | $6 |
| Pembrolizumab injection (Keytruda) | 6,800 | $43 | $137 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
2,385 | $2 | $20 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,385 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,240 | $1 | $114 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
616 | $8 | $35 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
516 | $84 | $1,348 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
456 | $2 | $300 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
440 | $8 | $19 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
435 | $19 | $144 |
| Injection, granisetron hydrochloride, 100 mcg | 420 | $0 | $24 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
396 | $13 | $105 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 264 | $3 | $373 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
262 | $2 | $13 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
213 | $109 | $686 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
180 | $72 | $168 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
167 | $23 | $152 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
151 | $66 | $157 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
127 | $54 | $334 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
124 | $1 | $9 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
91 | $106 | $231 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
85 | $23 | $156 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
79 | $98 | $232 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
77 | $12 | $93 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
71 | $2 | $19 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
69 | $138 | $343 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
66 | $11 | $73 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
63 | $7 | $431 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
60 | $35 | $139 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
59 | $53 | $304 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
53 | $109 | $297 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
49 | $1 | $7 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
43 | $15 | $108 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
42 | $27 | $249 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
41 | $1 | $19 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
39 | $145 | $412 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
34 | $42 | $115 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
33 | $213 | $1,726 |
| Injection, leucovorin calcium, per 50 mg | 31 | $3 | $25 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
30 | $60 | $205 |
| New patient office visit, complex (60-74 min) | 26 | $181 | $432 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
15 | $59 | $289 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $144 | $325 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
2.0% high complexity
91.1% medium
6.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,732
Total received (2019-2024)
Avg $1,289/year across 6 years
Top 34% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
226
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,085
2023
$2,016
2022
$1,284
2021
$1,128
2020
$384
2019
$834
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$397
Merck Sharp & Dohme LLC
$161
ABBVIE INC.
$152
PFIZER INC.
$137
E.R. Squibb & Sons, L.L.C.
$97
Astellas Pharma US Inc
$95
AstraZeneca Pharmaceuticals LP
$95
GENZYME CORPORATION
$80
GlaxoSmithKline, LLC.
$75
Adaptive Biotechnologies Corporation
$71
TerSera Therapeutics LLC
$67
Incyte Corporation
$65
Daiichi Sankyo Inc.
$58
Gilead Sciences, Inc.
$51
JAZZ PHARMACEUTICALS INC.
$49
EMD Serono, Inc.
$47
Eisai Inc.
$44
Takeda Pharmaceuticals U.S.A., Inc.
$32
Celgene Corporation
$31
Fennec Pharmaceuticals, Inc.
$31
Janssen Biotech, Inc.
$31
INTUITIVE SURGICAL, INC.
$30
Tempus AI, Inc
$30
Regeneron Healthcare Solutions, Inc.
$29
Exelixis Inc.
$24
Pharmacosmos Therapeutics Inc.
$24
Mirati Therapeutics, Inc.
$22
Bayer Healthcare Pharmaceuticals Inc.
$22
SERVIER PHARMACEUTICALS LLC
$20
PUMA BIOTECHNOLOGY, INC.
$18
Top 3 companies account for 34.1% of 2024 payments
All-time payments by company (2019-2024) ›
Incyte Corporation
$797
Seagen Inc.
$668
Novartis Pharmaceuticals Corporation
$549
Exelixis Inc.
$423
Astellas Pharma US Inc
$364
PFIZER INC.
$332
GENZYME CORPORATION
$317
Merck Sharp & Dohme LLC
$221
Pharmacyclics LLC, An AbbVie Company
$219
ABBVIE INC.
$211
Takeda Pharmaceuticals U.S.A., Inc.
$207
AstraZeneca Pharmaceuticals LP
$203
Epizyme, Inc.,
$190
Janssen Biotech, Inc.
$177
Amgen Inc.
$176
SANOFI-AVENTIS U.S. LLC
$174
Gilead Sciences, Inc.
$166
JAZZ PHARMACEUTICALS INC.
$151
BeiGene USA, Inc.
$146
GlaxoSmithKline, LLC.
$139
Merck Sharp & Dohme Corporation
$136
EMD Serono, Inc.
$129
Regeneron Healthcare Solutions, Inc.
$125
ADC Therapeutics America, Inc.
$123
Eisai Inc.
$112
Lilly USA, LLC
$108
Agios Pharmaceuticals, Inc.
$103
Seattle Genetics, Inc.
$99
E.R. Squibb & Sons, L.L.C.
$97
Adaptive Biotechnologies Corporation
$88
Daiichi Sankyo Inc.
$82
Pharmacosmos Therapeutics Inc.
$73
TerSera Therapeutics LLC
$67
Bayer Healthcare Pharmaceuticals Inc.
$64
Puma Biotechnology, Inc.
$38
Janssen Pharmaceuticals, Inc
$36
PharmaEssentia USA Corporation
$33
Celgene Corporation
$31
Fennec Pharmaceuticals, Inc.
$31
INTUITIVE SURGICAL, INC.
$30
Tempus AI, Inc
$30
Stemline Therapeutics Inc.
$26
G1 Therapeutics, Inc.
$25
CTI BioPharma Corp.
$24
Mirati Therapeutics, Inc.
$22
Coherus Biosciences Inc.
$21
SERVIER PHARMACEUTICALS LLC
$20
Servier Pharmaceuticals LLC
$20
Apellis Pharmaceuticals, Inc.
$20
Alexion Pharmaceuticals, Inc.
$19
MorphoSys, US Inc.
$19
Secura Bio, Inc.
$18
PUMA BIOTECHNOLOGY, INC.
$18
Karyopharm Therapeutics Inc.
$13
Top 3 companies account for 26.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · BAVENCIO · BESREMI · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · COPIKTRA · COSELA · CREON · Cabometyx · Cresemba · DARZALEX · Da Vinci Surgical System · ELIQUIS · ELITEK · ENJAYMO · ERLEADA · Empaveli · Enhertu · Fabhalta · HYQVIA · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MONJUVI · MONOFERRIC · NERLYNX · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PYRUKYND · Padcev · Pedmark · Pomalyst · Prolia · RETEVMO · RYBREVANT · SARCLISA · SCEMBLIX · TAGRISSO · TASIGNA · TAZVERIK · TECVAYLI · TEPMETKO · TIBSOVO · TUKYSA · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VELCADE · VENCLEXTA · VERZENIO · Vanflyta · Vonjo · XALKORI · XARELTO · XPOVIO · Xermelo · Xospata · Xtandi · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
278
County median income
$81,797
Nearest hospital to ZIP centroid (approximate)
NORTHWEST COMMUNITY HOSPITAL 1
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Esmail is a mixed practice specialist, with above-average Medicare volume (top 25% in IL).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Esmail experienced with anti-nausea injection (fosaprepitant)?
Based on Medicare claims data, Esmail performed 18,150 anti-nausea injection (fosaprepitant) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Esmail receive payments from pharmaceutical companies?
Yes. Esmail received a total of $7,732 from 54 companies across 226 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Esmail's costs compare to other hematology & oncology specialists in Arlington Heights?
Esmail's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Esmail) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Arlington Heights
Browse hematology & oncology specialists in Arlington Heights ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in IL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in IL
Which IL hematology & oncology specialists receive the most from drug and device companies.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology